E Fund Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73M | Buy |
13,810
+423
| +3% | +$53.1K | 0.08% | 122 |
|
|
2025
Q1 | $1.83M | Buy |
13,387
+3,160
| +31% | +$432K | 0.09% | 119 |
|
|
2024
Q4 | $1.56M | Buy |
10,227
+2,166
| +27% | +$331K | 0.08% | 126 |
|
|
2024
Q3 | $1.56M | Buy |
8,061
+994
| +14% | +$193K | 0.08% | 101 |
|
|
2024
Q2 | $1.64M | Buy |
7,067
+2,884
| +69% | +$669K | 0.09% | 94 |
|
|
2024
Q1 | $902K | Buy |
4,183
+128
| +3% | +$27.6K | 0.06% | 120 |
|
|
2023
Q4 | $1.05M | Buy |
4,055
+353
| +10% | +$91.3K | 0.07% | 89 |
|
|
2023
Q3 | $951K | Buy |
3,702
+630
| +21% | +$162K | 0.07% | 84 |
|
|
2023
Q2 | $875K | Sell |
3,072
-365
| -11% | -$104K | 0.07% | 84 |
|
|
2023
Q1 | $956K | Sell |
3,437
-74
| -2% | -$20.6K | 0.07% | 86 |
|
|
2022
Q4 | $972K | Sell |
3,511
-1,128
| -24% | -$312K | 0.08% | 91 |
|
|
2022
Q3 | $1.24M | Buy |
4,639
+235
| +5% | +$62.8K | 0.12% | 78 |
|
|
2022
Q2 | $898K | Buy |
4,404
+833
| +23% | +$170K | 0.08% | 96 |
|
|
2022
Q1 | $752K | Buy |
3,571
+590
| +20% | +$124K | 0.02% | 99 |
|
|
2021
Q4 | $715K | Buy |
2,981
+225
| +8% | +$54K | 0.03% | 127 |
|
|
2021
Q3 | $780K | Buy |
+2,756
| New | +$780K | 0.03% | 104 |
|
|
2021
Q1 | $745K | Buy |
+2,662
| New | +$745K | 0.06% | 107 |
|